ClinicalTrials.gg
CompletedNCT00324233Updated Jan 1, 2013Results posted

Evaluation of Residual Urine After Intermittent Catheterisation

An interventional study of Intermittent catheter and Compact intermittent catheter in Healthy, sponsored by Coloplast A/S. Completed at 1 site in Denmark. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-01-01.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

Intermittent catheterization is a well-known method used for emptying the bladder. The objective of this study is to compare the residual urine after intermittent catheterisation with 2 different, hydrophilic coated, intermittent catheters. The study is a randomized, single blinded, crossover study including 24 healthy males.

02

Conditions studied

  • Healthy

Browse trials for

Keywords

  • Residual urine
  • Hematuria
  • Ultra sound
03

In context

Hematuria

61 studies on the registry are indexed under Hematuria; 18 are open to participants now.

This study's enrollment of 36 is below the median of 86 across 34 interventional studies indexed under Hematuria.

Browse Hematuria studies →

Lead sponsor

Coloplast A/S is the lead sponsor of 150 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male
  • 18 years and above
  • A negative urine dip-stick
  • Have signed informed written consent to participate

Exclusion criteria

Exclusion Criteria:

  • The test participant has previous or current congenital deformity, diseases or operation in the lower urinary tract
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Active comparator
    SC

    Speedicath (SC) catheter is a catheter for intermittent catherisation

    Device: Intermittent catheter

  • Experimental
    SCCM

    SpeediCath Compact Male (SCCM) is a compact catheter for intermittent catherisation to be used by males

    Device: Compact intermittent catheter

Interventions

  • DeviceIntermittent catheter

    SpeediCath catherter (SC) for intermittent catherisation

  • DeviceCompact intermittent catheter

    SpeediCath Compact Male catheter (SCCM) is a compact intermittent catheter for males

06

What researchers measure

Primary outcomes

  1. Residual Urine Measured by Ultra Sound

    Time frame: 2

Secondary outcomes

  1. Subjectively Measured Handling

  2. Subjectively Measured Insertion of the Catheter

07

Results

Posted Jan 1, 2013

Participant flow

First Period
Participant flow — First Period
MilestoneSC Then SCCMSCCM Then SC
Started1818
Completed1718
Not completed10
Withdrew: Unable to insert catheter10
Second Period
Participant flow — Second Period
MilestoneSC Then SCCMSCCM Then SC
Started1718
Completed1211
Not completed57
Withdrew: Unable to insert catheter11
Withdrew: Protocol violation46

Outcome measures

PrimaryResidual Urine Measured by Ultra Sound
Time frame:
2
Reported as:
Mean · ml
Residual Urine Measured by Ultra Sound
mlSpeediCathSpediCath Compact Male
Residual Urine Measured by Ultra Sound11 ± 306 ± 23
Statistical analysis
  • SpeediCath vs SpediCath Compact Male · equivalence testing · p = 0.56
SecondarySubjectively Measured Handling

Results for this outcome have not been posted.

SecondarySubjectively Measured Insertion of the Catheter

Results for this outcome have not been posted.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
SC Then SCCM—0/18 (0%)0/18 (0%)
SCCM Then SC—0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)SC Then SCCMSCCM Then SCTotal
<=18 years000
Between 18 and 65 years181836
>=65 years000
Age Continuous
Age Continuous(years)SC Then SCCMSCCM Then SCTotal
Mean23.6 ± 3.023.9 ± 2.923.7 ± 2.9
Sex: Female, Male
Sex: Female, Male(Participants)SC Then SCCMSCCM Then SCTotal
Female000
Male181836
Region of Enrollment
Region of Enrollment(participants)SC Then SCCMSCCM Then SCTotal
Denmark181836
08

Study locations

1 site
  • Rigshospitalet
    Copenhagen, København Ø 2100, Denmark
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 1, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00324233
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
May 10, 2006
Start date
Apr 2006
Primary completion
Jun 2006
Completion
Jun 2006
Results posted
Jan 1, 2013
Last update
Jan 1, 2013

Study contacts

Per Bagi, MD
principal investigator · Copenhagen University Hospital, Rigshospitalet
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion